Israel's Mitoconix Bio raises $20 mln in private funding round
JERUSALEM, June 27 Mitoconix Bio, an Israeli biopharmaceutical company focused on treating neurological diseases, said on Tuesday it raised $20 million in an early funding round.
Feb 9 Summit State Bank -
* Summit State Bank declares stock split
* Five-for-four stock split declared for common shareholders Source text for Eikon: Further company coverage:
* Says TCS baNCS to power TMX Group with new consolidated technology platform Source text: http://bit.ly/2scmlBu Further company coverage:
* Currently in negotiations, which if successfully concluded, may have a material effect on price of company's securities Source text for Eikon: Further company coverage: